Evidence map›Paper›PMID 42510151›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Integrated TCRγ Clonality Workflow for Molecular Diagnosis in HTLV-1 Carriers and Adult T-Cell Leukemia/Lymphoma.

Davi Ferreira Jofre, Giulia Sales Guimarães, Ana Beatriz Rocha, Jéssica Bilar Cavalcanti, Priscila de Lima Barros, Karine Sobral Marques, Nélio Cézar de Aquino, Vinícius de Camargo Callefi, Isadora Alves, Lilian de Souza França and 10 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Davi Ferreira JofreLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0009-0000-3585-2105
Giulia Sales GuimarãesLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.
Ana Beatriz RochaLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0009-0005-5105-7992
Jéssica Bilar CavalcantiLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0009-0000-2364-5598
Priscila de Lima BarrosLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0009-0004-3222-9990
Karine Sobral MarquesLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.
Nélio Cézar de AquinoLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0000-0003-3769-933X
Vinícius de Camargo CallefiLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0009-0002-6584-6413
Isadora AlvesLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0009-0005-2024-8278
Lilian de Souza FrançaLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0009-0000-7169-532X
Letícia Montanha de AssisLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.
Sheila de Oliveira Garcia MateosDepartment of Research and Innovation, Campus Medicine, Municipal University of Sao Caetano do Sul, Sao Caetano 09521-160, Brazil.ORCID 0000-0001-5416-2724
Carolina RosadasSection of Virology, Department of Infectious Diseases, Faculty of Medicine, Imperial College, London W2 1PG, UK.ORCID 0000-0002-3922-5667
Jorge Simão do Rosário CassebLaboratory of Medical Investigation in Dermatology and Immunodeficiencies (LIM-56), Instituto de Medicina Tropical (IMT), Faculty of Medicine, University of São Paulo, Sao Paulo 05403-907, Brazil.
Youko NukuiClinical Hospital of the University of Sao Paulo Medical School (HC-FMUSP), Sao Paulo 05419-000, Brazil.
Vanderson RochaLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.
Luís Alberto de Pádua Covas LageLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0000-0002-9228-3276
Cadiele Oliana ReichertLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.
Juliana PereiraLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0000-0002-0655-2821
Hebert Fabricio CullerLaboratory of Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy, and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05419-000, Brazil.ORCID 0000-0001-6850-8247

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 403690/2024-2Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.912712/2023-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/03163-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/09971-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/18471-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/18474-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2025/16142-6
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adult T-cell leukemia/lymphomaclonalityEuroClonalityHTLV-1molecular diagnosticsmultiplex PCRT-cell receptor gamma

Identifiers

PMID42510151
PMCPMC13407627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.